Synergism between β2-adrenoceptor agonists and subtype-selective α1A-adrenoceptor antagonists in the tocolytic effect on pregnant rat uterus in vitro

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 3, 2003, Pages 164-167

  Mihalyi A ^a   Gaspar R ^a   Csonka, D ^a   Falkay, George ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

1A adrenoceptor antagonists; 2 adrenoceptor agonists; Combination; Electric field stimulation; Rat; Tocolysis

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 5 METHYLURAPIDIL; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; RITODRINE; TERBUTALINE;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG MIXTURE; DRUG POTENTIATION; ELECTROSTIMULATION; FEMALE; MYOMETRIUM; NONHUMAN; PREMATURE LABOR; RAT; TOCOLYSIS; UTERUS; UTERUS CONTRACTION; UTERUS RELAXATION;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; DRUG SYNERGISM; FEMALE; MUSCLE RELAXATION; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-2; TOCOLYTIC AGENTS; UTERUS;

EID: 0037346025     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03811.x     Document Type: Article

References (13)

1. Norwitz ER, Robinson JN. A systematic approach to the management of preterm labor. Semin. Perinatol. 2001; 25: 223-35.
2. Hill WC. Risks and complications of tocolysis. Clin. Obstet. Gynecol. 1995; 38: 725-45.
3. Katz VL, Farmer RM. Controversies in tocolytic therapy. Clin. Obstet. Gynecol. 1999; 42: 802-19.
4. Rozenberg P. Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: A critical review. J. Gynecol. Obstet. Biol. Reprod. 2001; 30: 221-30.
5. Gemelli M, De Luca F, Manganaro R et al. Transient electrocardiographic changes suggesting myocardial ischaemia in newborn infants following tocolysis with beta-sympathomimetics. Eur. J. Pediatr. 1990; 149: 730-3.
6. Lampert MB, Hibbard J, Weinert L, Briller J, Lindheimer M, Lang RM. Peripartum heart failure associated with prolonged tocolytic therapy. Am. J. Obstet. Gynecol. 1993; 168: 493-5.
7. Drault JN, Kaidomar S, Schaub B, Mehdaoui H, Herbland A, Cidolit E. Acute pulmonary edema caused by tocolytic therapy with salbutamol. Presse Med. 2001; 30: 112-14.
8. Engelhardt S, Zieger W, Kassubek J, Michel MC, Lohse MJ, Brodde OE. Tocolytic therapy with fenoterol induces selective down-regulation of β-adrenergic receptors in human myometrium. J. Clin. Endocrinol. Metab. 1997; 82: 1235-42.
9. Legrand C, Maltier JP. Evidence for a noradrenergic transmission in the control of parturition in the rat. J. Reprod. Fertil. 1986; 76: 415-24.
10. Ducza E, Gáspár R, Falkay G. Altered levels of mRNA expression and pharmacological reactivity of alpha-1A adrenergic receptor subtypes in the late-pregnant rat myometrium. Mol. Reprod. Dev. 2002; 62: 343-7.
11. 1A-adrenergic receptor in the contractility of the rat uterus post partum. Mol. Pharmacol. 2001; 59: 1235-42.
12. Wacker J, Werner P, Walter-Sack I, Bastert G. Treatment of hypertension in patients with pre-eclampsia: A prospective parallel-group study comparing dihydralazine with urapidil. Nephrol. Dial. Transplant. 1998; 13: 318-25.
13. Baldwin KJ, Leighton NA, Kilby MD, Wyldes M, Churchill D, Johanson RB. The West Midlands 'Severe Hypertensive Illness in Pregnancy' (SHIP) audit. Hypertens. Pregnancy 2001; 20: 257-68.